JPMorgan raises AbbVie target price to $300
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui October 10｜JPMorgan has raised the target price of AbbVie from $285 to $300 and maintained an "Overweight" rating.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Morgan Stanley raises CME Group price target to $337
格隆汇•2026/10/10 07:37
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories
Chaincatcher•2026/10/10 07:19
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
智通财经•2026/10/10 06:21
Crypto prices
More
Bitcoin
BTC
$82,749.82
+0.25%
Ethereum
ETH
$2,492.04
-0.31%
Tether USDt
USDT
$0.9990
-0.01%
BNB
BNB
$749.37
+0.70%
XRP
XRP
$1.41
+0.20%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$109.86
-0.46%
TRON
TRX
$0.3307
-0.38%
Hyperliquid
HYPE
$84.39
-1.82%
Zcash
ZEC
$1,227.39
+0.10%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now